FMP
Invesco Dynamic Biotechnology & Genome ETF
PBE
AMEX
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
67.35 USD
-0.1855 (-0.275%)
About
ceo
N/A
sector
Financial Services
industry
Asset Management
website
N/A
exchange
AMEX
Description
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
CIK
0001209466
ISIN
US46137V7872
CUSIP
46137V787
Address
N/A
Phone
NA
Country
US
Employee
N/A
IPO Date
Jun 23, 2005
Key Executives
